Back to results
US 2024/0366816 A1Published application
Structural Optimization Method to Improve the Theranostic Performance of Peptide Receptor-Targeted Radionuclide Therapy for Cancers
AssigneeUniversity of Iowa Research Foundation
InventorsDongyoul Lee, Michael K. Schultz, Mengshi Li, Nicholas Baumhover, F. Christopher Pigge
Life of this patent
Estimating the term…
Abstract
The present invention provides in certain embodiments a carcinoma-targeting conjugate comprising Formula I: T-L-X wherein T is a SSTR2 targeting ligand, L is a linker, and X is a chelator, for the therapeutic treatment of cancer, and methods of use thereof.
Claims15
A compound having the Formula I:
- T-L-X;
- Formula I,
- wherein T is a somatostatin receptor subtype 2 (SSTR2) targeting ligand with the following structure:
- wherein the wavy line “” indicates covalent attachment to a chelator or a linker;
- wherein L is a linker, wherein the linker is a polyethylene glycol (PEGn), and wherein n=0-10;
- and wherein X is a chelator with the following structure:
- wherein the wavy line “” indicates covalent attachment to a linker or an SSTR2 targeting ligand.
4 more elements
Dependencies are inferred from the claim text.